Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.58+0.20 (+3.72%)
At close: 04:00PM EDT
5.58 0.00 (0.00%)
After hours: 07:53PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • 💊C
    IMVT’s 1402, if it can be dosed like 1401, will be either a 340 or 680mg SC shot with potentially the highest in class anti-FcRn efficacy and no LDL issue. For comparison, Vyvgart is a 1000mg shot that has to be mixed with halozyme, which dissolves the gel under your skin. Tolerability will matter to patients with chronic administration and the gap between 1402 and Vyvgart will be more than Pfizer vs Moderna vaxs. Vyvgart is owned by ARGX, market cap 20B, while IMVT is 700M at $6.
    Bullish
  • P
    PJB
    Right, let’s get to 8!
  • J
    Joe
    With patience and time $20 plus
    Bullish
  • 💊C
    The director Torti Frank bought 20k shares on the open market today at $5.81 🌾👀🌾
    Bullish
  • P
    PJB
    Nice
    Bullish
  • 💊C
    Roivant owns nearly 70% and the rest of the longs aren’t going to sell it here, so any drop is just shorties doing their thing
    Bullish
  • 💊C
    They have cash thru 2025 for anyone interested
    Bullish
  • B
    Bob
    Please take a look at ticker ILUS as well - ILUS International: EVs, Drones, UAVs, Urban Mining and patented firefighting and safety technology. ILUS is uplisting in 2022. They have increased their year over year revenue by 588 percent, and their quarterly revenue by 553 percent. They have been profitable every quarter since inception. Please see Yahoo Finance for more details and news. ILUS is worth a look.
    Bullish
  • M
    Middlesworth
    Are you ready to make money in the stock market? (http://growthstocks.club) has you covered! Get our report with 5 MUST BUY growth stocks that could each rise 391%!
  • J
    Joe
    WATCH here we come
    Bullish
  • G
    GUNNIP
    Guys, check out (http://Achieverspot.tech). They have been crushing it lately while IMVT barley does anything at all.
  • M
    Market Shares
  • M
    MN
    $HZNP conversation
    Horizon Tepezza competition:

    Immunovant $IMVT Announces Voluntary Pause in Clinical Dosing of IMVT-1401

    physiological signal consisting of elevated total cholesterol and LDL levels in IMVT-1401-treated patients in ASCEND GO-2 Phase 2b in Thyroid Eye Disease (TED)
  • C
    Conor
    will this ever go back to 35$ range?
  • C
    CGSC
    Sure would be nice to get some sort of news.
    Bullish
  • D
    Derrick and Valerie
    Am I correct in that IMVT’s last communication was Feb 16th! Since then there has been zero updates from the company. During this time, several law firms have been posting daily reminders as a strategy to discourage people from buying the stock. No wonder the price of IMVT is not appreciating.
Advertisement
Advertisement